Join this live webinar to learn more.
As global uncertainty grows, biotech and biopharma companies are rethinking manufacturing strategies to reduce risk and ensure continuity. Onshoring drug substance development for biologics offers a powerful way to strengthen control, improve reliability, and accelerate timelines. This webinar will explore the strategic advantages of onshoring, including streamlined regulatory compliance, improved process oversight, and greater flexibility for innovation. Industry experts will share practical insights on planning and executing onshore transitions, technology considerations, and how these efforts can safeguard critical programs. Join us to learn why onshoring is becoming a cornerstone of risk mitigation and long-term success in biologics manufacturing.
Offered Free by: Avid Bioservices
See All Resources from: Avid Bioservices
